Cigna Corp (NY: CI )

333.56 +3.65 (+1.11%)
Official Closing Price Updated: 4:10 PM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,144,004
Open 327.01
Bid (Size) 316.26 (1)
Ask (Size) 337.34 (1)
Prev. Close 329.91
Today's Range 327.01 - 333.84
52wk Range 253.95 - 365.71
Shares Outstanding 340,107,539
Dividend Yield 1.47%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 of the Best Stock Buybacks So Far in 2024
S&P 500 companies made nearly $240 billion in stock buybacks in the first quarter, 9.9% higher than a year ago. Here are three of the best. 
Via InvestorPlace
Topics Stocks
Exposures US Equities

Performance

YTD
+7.57%
+7.57%
1 Month
-1.50%
-1.50%
3 Month
-6.79%
-6.79%
6 Month
+8.40%
+8.40%
1 Year
+18.39%
+18.39%

More News

Read More
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,400 Today
Via Benzinga
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth
Via Benzinga
Looking Into Cigna Group's Recent Short Interest
Via Benzinga
Decoding Cigna Group's Options Activity: What's the Big Picture?
Via Benzinga
What Analysts Are Saying About Cigna Group Stock
Via Benzinga
Here's How Much $1000 Invested In Cigna Group 5 Years Ago Would Be Worth Today
Via Benzinga
When you look at NYSE:CI, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via Chartmill
Why Walgreens Boots Alliance Plunged in June
Via The Motley Fool
Investors should take note of NYSE:CI, a growth stock that remains attractively priced.
Via Chartmill
Down Over 60%, Is Walgreens Boots Alliance a Bad-News Buy?
Via The Motley Fool
Elevance Stock Elevated On Excellent Marketing Execution
Via Investor's Business Daily
Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says
Via Benzinga
Despite its growth, NYSE:CI remains within the realm of affordability.
Via Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today
Via Benzinga
Forecasting The Future: 12 Analyst Projections For Cigna Group
Via Benzinga
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Via InvestorPlace
NYSE:CI appears to be flying under the radar despite its strong fundamentals.
Via Chartmill
10 Value Stocks With Low Debt And Strong Growth
Via Talk Markets
Combatting the Loneliness Epidemic: The Role of Muah AI in Providing Emotional Support
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Via Benzinga
Top-rated Medicaid Practice, Denver Youth Dentistry and Orthodontics Removes Barriers to Quality Dental Care for Children in Denver
Via Get News
Class Lawsuit Alleges Cigna Discriminates by Excluding Obesity Drugs
Via 24-7 Press Release
Topics Lawsuit
Exposures Financial Legal
Centene Reaffirms Guidance, But Is it Too Late?
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.